Evidence supporting the use of: Salmon Oil
For the health condition: Congestive Heart Failure

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Salmon oil is a rich source of omega-3 polyunsaturated fatty acids, mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Scientific evidence supports the use of omega-3 fatty acids as an adjunct therapy in the management of congestive heart failure (CHF), both in humans and in veterinary medicine, particularly in dogs. Multiple clinical trials and meta-analyses have demonstrated that omega-3 supplementation can reduce morbidity and mortality in patients with heart failure, likely through several mechanisms: anti-inflammatory effects, antiarrhythmic properties, reduction in blood triglycerides, and improved endothelial function. In dogs, peer-reviewed studies have reported that dietary supplementation with fish oil, including salmon oil, can improve appetite, reduce cardiac cachexia (muscle wasting), decrease arrhythmias, and improve overall quality of life in CHF. In humans, omega-3 fatty acids are recommended by some cardiology guidelines as adjunctive therapy for heart failure patients to reduce hospitalization and death. However, the overall effect size is moderate, and not all studies show significant benefits, leading to a moderate strength of evidence (rated 3 out of 5). In summary, the use of salmon oil for CHF is supported by scientific evidence, though it is typically considered adjunctive therapy rather than a primary treatment, and should be used under medical or veterinary supervision.

More about Salmon Oil
More about Congestive Heart Failure

Products containing Salmon Oil

We currently have no products on Vitabase that contain this ingredient.